Sharemaestro Newsreel

Spotlight On Tempus AI And 2 Other Leading Insider-Owned Growth Stocks

HC Wainwright Predicts Reduced Earnings for SOPHiA GENETICS

HC Wainwright has lowered its FY2029 earnings per share forecast for SOPHiA GENETICS (NASDAQ: SOPH) to $0.31 from $0.34, while maintaining a Buy rating and a $14 price target. The company recently reported a quarterly loss of $0.26 per share, missing consensus estimates, despite …

CareCloud Number of Employees 2026 | Employee Count & Headcount Data

CareCloud, Inc. (CCLD) had approximately 3,671 employees worldwide as of March 2026, marking a 13.1% decline from 2023. The company is actively hiring, with 74 job postings in 2026, a 17.6% increase from 2025. CareCloud's workforce is concentrated in South Asia, and the global …

Privia Health (NASDAQ: PRVA) lifts Q2 2026 revenue, margins and expands credit line

Privia Health Group, Inc. (NASDAQ: PRVA) reported significant financial growth for Q2 2026, with revenue increasing to $632.6 million and net income rising to $9.0 million. The company also expanded its revolving credit facility to $250 million with no outstanding borrowings, demonstrating strong liquidity. …

Privia Health (NASDAQ:PRVA) Surprises With Q2 CY2026 Sales

Evolent Health (EVH) Tops Q2 Earnings and Revenue Estimates

Carlsmed Q2 2026 revenue up 57% to USD 18.9M

Carlsmed, Inc. reported a 57% year-over-year revenue increase to $18.9 million for Q2 2026, driven by strong growth in aprevo® procedures. The company expanded gross margins, grew its surgeon user base, and anticipates continued growth, partly due to a new CMS ruling enhancing reimbursement …

For over a decade, most U.S. News Honor Roll hospitals have used Spok

Spok, Inc. announced that 18 out of the 20 adult hospitals recognized on the 2026-2027 U.S. News & World Report Best Hospitals Honor Roll utilize Spok technology for care coordination. This continues a trend of the majority of Honor Roll hospitals leveraging Spok solutions …

Bitcoin miner explores modular reactors for up to 100 MWe

Mangoceuticals announced that its merger partner, Nuclea Energy Inc., signed a non-binding MOU with New Mining Co. to assess the deployment of Nuclea's modular reactor technology for New Mining's high-density computing and Bitcoin mining operations. The evaluation will proceed in phases, starting with engineering …

Privia Health beats Q2 estimates, issues 2026 guidance

Privia Health Group, Inc. (NASDAQ:PRVA) reported strong second-quarter results, exceeding analyst expectations with adjusted EPS of $0.19 and revenue of $632.6 million. The company also issued its first fiscal year 2026 revenue guidance, projecting between $2.35 billion and $2.45 billion, with the midpoint slightly …

VSee Health Faces Nasdaq Trading Suspension and Delisting

VSee Health is facing suspension and delisting from Nasdaq due to its stock consistently trading below $1.00 and recently falling to $0.10 or less for ten consecutive days. The company, which previously received a 180-day grace period, may request a hearing but cautions that …

Evolent Announces Second Quarter 2026 Results

Privia Health Group Reports Second Quarter 2026 Results, Raises Full-Year Guidance

Privia Health Group (PRVA) announced strong second-quarter 2026 financial results, with net income rising 236.7% to $9.0 million and adjusted EBITDA increasing 29.1% to $37.4 million. Total revenue grew 21.4% to $632.6 million, leading the company to raise its full-year 2026 guidance across all …

Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU

Mangoceuticals, Inc. announced that its merger partner's subsidiary, Nuclea Energy USA Inc., signed a memorandum of understanding (MOU) with the Utah Office of Energy Development. This MOU aims to explore siting a nuclear test reactor at the Utah San Rafael Energy Lab to advance …

Why is Mangoceuticals stock surging today?

Mangoceuticals (MGRX) stock surged over 31% in pre-open trading after its merger partner, Nuclea Energy Inc., announced a key regulatory milestone for its Morpheus microreactor program. This development involves a memorandum of understanding to explore siting a nuclear test reactor in Utah, bolstering investor …

SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares

SOPHiA GENETICS (NASDAQ:SOPH) insider Zhenyu Xu sold 10,000 shares of the company's stock on August 4th, reducing their position by 1.64%. The transaction, valued at $69,200, was conducted under a pre-arranged Rule 10b5-1 plan. Despite the insider sale and a recent stock dip, analysts …

10x Genomics, Inc. (TXG) stock price, news, quote and history

This Yahoo Finance page provides a comprehensive overview of 10x Genomics, Inc. (TXG), including its current stock price, recent news, chart performance over various periods, and key financial data. The article details the company's products and services, such as the Chromium and Visium platforms …

Truist raises Carlsmed stock price target on strong growth outlook

Truist Securities has increased its price target for Carlsmed Inc. to $20 from $18, maintaining a Buy rating. This adjustment follows Carlsmed's strong second-quarter results, which included 57% revenue growth and an improved full-year outlook. The company's financial health is further supported by a …

(LFMDP) Risk Channels and Responsive Allocation

This article provides an AI-driven analysis of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), noting a neutral sentiment and a wait-and-see approach. It highlights an exceptional 12.0:1 risk-reward setup targeting a 3.6% gain, with specific trading strategies for position trading, …

38,126 Shares in Heartflow, Inc. $HTFL Purchased by Lazard Asset Management LLC

Lazard Asset Management LLC recently acquired 38,126 shares of Heartflow, Inc. (NASDAQ:HTFL), valued at approximately $928,000, as part of new institutional investment in the company. Despite positive analyst ratings, with a "Moderate Buy" consensus and a $36.57 average price target, insiders have sold 115,805 …

Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating Teladoc Health, Inc. (TDOC) on behalf of investors following a significant drop in its stock price. This drop occurred after Teladoc reported lower-than-expected Q2 2026 revenue and subsequently reduced its full-year 2026 revenue guidance. The firm cites …

SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics

SOPHiA GENETICS has announced a multi-year global partnership with AstraZeneca to develop and launch two companion diagnostics for precision oncology therapies. This collaboration aims to create decentralised clinical trial assays and diagnostic solutions for both solid tumors and blood cancers. The goal is to …

MiniMed Group (NASDAQ: MMED) says General Counsel Courtney Nelson Wills will step down

MiniMed Group (NASDAQ: MMED) announced that its Senior Vice President, General Counsel, and Corporate Secretary, Courtney Nelson Wills, will resign effective September 25, 2026. Ms. Wills notified the company on July 30, 2026, and her departure is due to personal reasons, as she has …

Needham & Company LLC Reiterates "Hold" Rating for American Well (NYSE:AMWL)

Needham & Company LLC has reiterated its "Hold" rating for American Well (NYSE:AMWL), aligning with the broader analyst consensus and an average price target of $8.60. The company recently reported better-than-expected quarterly results, with adjusted EPS of $(0.59) against estimates of $(0.86) and revenue …

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has initiated a securities fraud investigation into Teladoc Health Inc. (TDOC) following a significant drop in its stock price. This investigation comes after Teladoc reduced its full-year revenue guidance and reported a more drastic reduction in BetterHelp's …

Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress

Mangoceuticals (MGRX) has received a second 180-day extension from Nasdaq, pushing its compliance deadline to February 1, 2027, to restore its stock price above $1.00. This extension provides flexibility as the company advances a definitive business combination agreement with Nuclea Energy Inc., an advanced …

Privia Health Group, Inc. Stock 12‑Month Price Target Raised to $32.11, Implies 35% Upside

Privia Health Group, Inc.'s average stock price target has increased from $31.89 to $32.11, according to estimates from 18 analysts. This updated target implies a 35% potential upside based on the Aug. 4 closing price, with forecasts ranging from $24 to $40 per share. …

LifeMD Reports Second Quarter 2026 Results, Reaches Branded GLP-1 Transition Milestone and Raises Full-Year Guidance

LifeMD, Inc. announced its Q2 2026 financial results, reporting revenues of $47.3 million and a sequential improvement in adjusted EBITDA loss to $3.5 million. The company is transitioning its weight management program to branded GLP-1 therapies, which now account for 95% of new patients, …

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Reduce" from Analysts

Simulations Plus, Inc. (NASDAQ:SLP) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $17.25, below its opening price of $18.32. This comes despite the company exceeding quarterly earnings expectations with an EPS of $0.30 and revenue of $21.89 …

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

Omada Health (OMDA) Earnings Date and Reports 2026

Omada Health members rose 45%; CEO change planned for Jan. 1

Phreesia schedules Sept. 2 call to discuss fiscal Q2 results

CareCloud Reports Second Quarter 2026 Results

CareCloud, Inc. (Nasdaq: CCLD) announced its financial results for the second quarter of 2026, reporting a 16% increase in revenue to $31.9 million and its ninth consecutive quarter of positive GAAP net income. The company also expanded into the compliance and audit-defense market through …

CareCloud, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CCLD) 2026-08-06

CareCloud (NASDAQ:CCLD) Issues Quarterly Earnings Results